In a bold move, a Turkish private equity firm has injected $39 million into a Harvard lab, aiming to pioneer new therapies for metabolic conditions. This unique financing approach could reshape academic funding in the future.
President Trump has issued a groundbreaking executive order that restricts federal funding for gain-of-function research, a controversial area of study linked to pandemic risks. While some hail the move as essential for public safety, others fear it may hinder vital scientific progress. Discover the implications of this bold decision and the heated debate surrounding it.
